{
  "resourceType": "StructureDefinition",
  "id": "AdverseReactionRiskSummaryAUCDI",
  "url": "https://aehrc.csiro.au/fhir/logical-models/AdverseReactionRiskSummaryAUCDI",
  "identifier": [
    {
      "system": "https://aehrc.csiro.au/id/archetype_id",
      "value": "openEHR-EHR-EVALUATION.adverse_reaction_risk.v2"
    }
  ],
  "version": "1.0.0",
  "name": "AdverseReactionRiskSummaryAUCDI",
  "title": "Adverse Reaction Risk Summary AUCDI",
  "status": "draft",
  "experimental": false,
  "date": "2023-09-11T00:54:09+10:00",
  "publisher": "CSIRO",
  "description": "The Adverse Reaction Risk Summary AUCDI Logical Model Mindmap is shown below.\n\n<div><img src='data:image/png;base64,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'/></div>\n\nA summary or overview of a clinical assessment that identifies the potential for a harmful or undesirable physiological reaction unique to an individual and associated with exposure to a specific substance.\n\n**Context**\n\nThis data group documents a clinician’s recommendation to avoid future exposure to a particular substance, emphasising the assessment of exposure risk and its substantiating evidence. In Release 1 the ‘Clinical evidence’ supporting the risk assessment is limited to the ‘Manifestation’ - symptoms or signs observed as part of an adverse reaction occurring on exposure to a substance. In future releases, it is anticipated that the details about the reaction event will be expanded and additional types of clinical evidence, such as immunogenetic test results can be included.\n\nWhile highlighting the clinical safety driver for accurately documenting adverse reactions, it is also important to recognise that such documentation within a clinical system will not always be limited to reactions categorised as true allergies, hypersensitivities, or intolerances. In practice, clinicians may encounter situations where the underlying pathophysiology of a reaction may not be known. Despite this, they still need to document that, in their judgment, the patient should avoid a specific substance. Such an entry is vital to prompt clinical safety alerts that prevent re-exposure, with previous manifestations offering insights into the risk of potential future harm, regardless of the unknown physiological mechanisms involved.\n\nUse cases include, but are not limited to:\n-   'Adverse Reaction List', or similar document, containing one or more ‘Adverse reaction summary’ data groups,\n-   Triggering clinical decision alerts when prescribing, dispensing and administering a medication, and\n-   To exchange safety-critical adverse reaction information with other healthcare providers.\n\n**Purpose**\n\nTo record:\n - An assessment of the risk or propensity of a future adverse reaction if exposed, or re-exposed, to an identified substance.\n - Evidence supporting the risk assessment, such as a summary of each exposure event or genomics test results.\n\n**Misuse**\n\n- Not to be used to record a diagnosis of an adverse reaction as the conclusion of a clinical consultation or investigation – use the Problem/Diagnosis data type for this purpose.\n - Not to be used for recording predictable physiological reactions on exposure to physical agents or activities, such as heat, cold, sunlight, vibration, exercise, by infectious agents, or food contaminants.\n - Not to be used to record adverse events, including failures of clinical processes, interventions, or products. For example, abnormal use, incorrect dosage or maladministration of an agent or substance, mislabelling, overdose, or poisoning.\n\n**Supported Models**\n\n-   Adverse reaction risk, Published archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2024 Feb 05]. Available from: [https://ckm.openehr.org/ckm/archetypes/1013.1.7022](https://ckm.openehr.org/ckm/archetypes/1013.1.7022)\n    \n-   Adverse reaction event, Published archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2024 Feb 05]. Available from: [https://ckm.openehr.org/ckm/archetypes/1013.1.5795](https://ckm.openehr.org/ckm/archetypes/1013.1.5795)\n    \n-   AllergyIntolerance, HL7 FHIR Resource [Internet]. Health Level Seven International; [cited: 2024 Feb 05]. Available from: [https://hl7.org/fhir/R5/allergyintolerance.html](https://hl7.org/fhir/R5/allergyintolerance.html).\n    \n-   AllergyIntolerance, International Patient Summary Implementation Guide, [Internet]. HL7 International / Patient care; [cited: 2024 Feb 05]. Available from: [https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-AllergyIntolerance-uv-ips.html](https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-AllergyIntolerance-uv-ips.html).\n\n**Considerations**\n\n- Substances include but are not limited to:\n\t - A therapeutic substance administered correctly at an appropriate dosage for the individual, including medications or vaccinations,\n\t - Food,\n\t - Material derived from plants or animals, or\n\t - Venom from insect stings.\n - Manifestations include any symptom, sign, or diagnosis.\n - It is also possible to record the absence of a reaction on re-exposure to a substance where an existing adverse reaction summary exists. This may trigger further investigation to confirm whether the previously assumed causal relationship to the substance is correct or mistaken.\n - This data group is intended to provide a single place within the health record to document the propensity for the full range of adverse reactions, from trivial to life-threatening, irrespective of the underlying physical mechanism. This includes but is not limited to:\n\t - Immune-mediated: Types I-IV (including allergic reactions and hypersensitivities); or\n\t - Non-immune-mediated: such as pseudo-allergic reactions, side effects, intolerances, and drug toxicities in individuals with impaired excretion.\n - In Release 1, all adverse reactions are assumed active in the context of a summary for exchange.\n - In future updates, it is anticipated this data group will be extended to incorporate additional detail.\n\n**Roadmap**\n\n\n\n<div><img src='data:image/png;base64,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'/></div>",
  "keyword": [
    {
      "system": "https://aehrc.csiro.au/fhir/CodeSystem/cdi-category",
      "code": "core"
    },
    {
      "system": "https://aehrc.csiro.au/fhir/CodeSystem/cdi-category",
      "code": "erequest"
    }
  ],
  "fhirVersion": "4.0.1",
  "kind": "logical",
  "abstract": false,
  "type": "https://aehrc.csiro.au/fhir/logical-models/AdverseReactionRiskSummaryAUCDI/AdverseReactionRiskSummary",
  "baseDefinition": "https://aehrc.csiro.au/fhir/logical-models/AdverseReactionRiskSummary",
  "derivation": "specialization",
  "differential": {
    "element": [
      {
        "id": "AdverseReactionRiskSummary",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "- Substances include but are not limited to:\n\t - A therapeutic substance administered correctly at an appropriate dosage for the individual, including medications or vaccinations,\n\t - Food,\n\t - Material derived from plants or animals, or\n\t - Venom from insect stings.\n - Manifestations include any symptom, sign, or diagnosis.\n - It is also possible to record the absence of a reaction on re-exposure to a substance where an existing adverse reaction summary exists. This may trigger further investigation to confirm whether the previously assumed causal relationship to the substance is correct or mistaken.\n - This data group is intended to provide a single place within the health record to document the propensity for the full range of adverse reactions, from trivial to life-threatening, irrespective of the underlying physical mechanism. This includes but is not limited to:\n\t - Immune-mediated: Types I-IV (including allergic reactions and hypersensitivities); or\n\t - Non-immune-mediated: such as pseudo-allergic reactions, side effects, intolerances, and drug toxicities in individuals with impaired excretion.\n - In Release 1, all adverse reactions are assumed active in the context of a summary for exchange.\n - In future updates, it is anticipated this data group will be extended to incorporate additional detail."
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-misuse",
            "valueString": "- Not to be used to record a diagnosis of an adverse reaction as the conclusion of a clinical consultation or investigation – use the Problem/Diagnosis data type for this purpose.\n - Not to be used for recording predictable physiological reactions on exposure to physical agents or activities, such as heat, cold, sunlight, vibration, exercise, by infectious agents, or food contaminants.\n - Not to be used to record adverse events, including failures of clinical processes, interventions, or products. For example, abnormal use, incorrect dosage or maladministration of an agent or substance, mislabelling, overdose, or poisoning."
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-purpose",
            "valueString": "To record:\n - An assessment of the risk or propensity of a future adverse reaction if exposed, or re-exposed, to an identified substance.\n - Evidence supporting the risk assessment, such as a summary of each exposure event or genomics test results."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-context",
            "valueString": "This data group documents a clinician’s recommendation to avoid future exposure to a particular substance, emphasising the assessment of exposure risk and its substantiating evidence. In Release 1 the ‘Clinical evidence’ supporting the risk assessment is limited to the ‘Manifestation’ - symptoms or signs observed as part of an adverse reaction occurring on exposure to a substance. In future releases, it is anticipated that the details about the reaction event will be expanded and additional types of clinical evidence, such as immunogenetic test results can be included.\n\nWhile highlighting the clinical safety driver for accurately documenting adverse reactions, it is also important to recognise that such documentation within a clinical system will not always be limited to reactions categorised as true allergies, hypersensitivities, or intolerances. In practice, clinicians may encounter situations where the underlying pathophysiology of a reaction may not be known. Despite this, they still need to document that, in their judgment, the patient should avoid a specific substance. Such an entry is vital to prompt clinical safety alerts that prevent re-exposure, with previous manifestations offering insights into the risk of potential future harm, regardless of the unknown physiological mechanisms involved.\n\nUse cases include, but are not limited to:\n-   'Adverse Reaction List', or similar document, containing one or more ‘Adverse reaction summary’ data groups,\n-   Triggering clinical decision alerts when prescribing, dispensing and administering a medication, and\n-   To exchange safety-critical adverse reaction information with other healthcare providers."
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-mapping",
            "valueString": "-   Adverse reaction risk, Published archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2024 Feb 05]. Available from: [https://ckm.openehr.org/ckm/archetypes/1013.1.7022](https://ckm.openehr.org/ckm/archetypes/1013.1.7022)\n    \n-   Adverse reaction event, Published archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2024 Feb 05]. Available from: [https://ckm.openehr.org/ckm/archetypes/1013.1.5795](https://ckm.openehr.org/ckm/archetypes/1013.1.5795)\n    \n-   AllergyIntolerance, HL7 FHIR Resource [Internet]. Health Level Seven International; [cited: 2024 Feb 05]. Available from: [https://hl7.org/fhir/R5/allergyintolerance.html](https://hl7.org/fhir/R5/allergyintolerance.html).\n    \n-   AllergyIntolerance, International Patient Summary Implementation Guide, [Internet]. HL7 International / Patient care; [cited: 2024 Feb 05]. Available from: [https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-AllergyIntolerance-uv-ips.html](https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-AllergyIntolerance-uv-ips.html)."
          }
        ],
        "path": "AdverseReactionRiskSummary",
        "short": "Adverse Reaction Risk Summary AUCDI",
        "definition": "A summary or overview of a clinical assessment that identifies the potential for a harmful or undesirable physiological reaction unique to an individual and associated with exposure to a specific substance.",
        "comment": "**Purpose**\n\nTo record:\n - An assessment of the risk or propensity of a future adverse reaction if exposed, or re-exposed, to an identified substance.\n - Evidence supporting the risk assessment, such as a summary of each exposure event or genomics test results.\n\n**Misuse**\n\n- Not to be used to record a diagnosis of an adverse reaction as the conclusion of a clinical consultation or investigation – use the Problem/Diagnosis data type for this purpose.\n - Not to be used for recording predictable physiological reactions on exposure to physical agents or activities, such as heat, cold, sunlight, vibration, exercise, by infectious agents, or food contaminants.\n - Not to be used to record adverse events, including failures of clinical processes, interventions, or products. For example, abnormal use, incorrect dosage or maladministration of an agent or substance, mislabelling, overdose, or poisoning.\n\n**Supporting Model(s)**\n\n-   Adverse reaction risk, Published archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2024 Feb 05]. Available from: [https://ckm.openehr.org/ckm/archetypes/1013.1.7022](https://ckm.openehr.org/ckm/archetypes/1013.1.7022)\n    \n-   Adverse reaction event, Published archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2024 Feb 05]. Available from: [https://ckm.openehr.org/ckm/archetypes/1013.1.5795](https://ckm.openehr.org/ckm/archetypes/1013.1.5795)\n    \n-   AllergyIntolerance, HL7 FHIR Resource [Internet]. Health Level Seven International; [cited: 2024 Feb 05]. Available from: [https://hl7.org/fhir/R5/allergyintolerance.html](https://hl7.org/fhir/R5/allergyintolerance.html).\n    \n-   AllergyIntolerance, International Patient Summary Implementation Guide, [Internet]. HL7 International / Patient care; [cited: 2024 Feb 05]. Available from: [https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-AllergyIntolerance-uv-ips.html](https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-AllergyIntolerance-uv-ips.html).\n\n**Considerations**\n\n- Substances include but are not limited to:\n\t - A therapeutic substance administered correctly at an appropriate dosage for the individual, including medications or vaccinations,\n\t - Food,\n\t - Material derived from plants or animals, or\n\t - Venom from insect stings.\n - Manifestations include any symptom, sign, or diagnosis.\n - It is also possible to record the absence of a reaction on re-exposure to a substance where an existing adverse reaction summary exists. This may trigger further investigation to confirm whether the previously assumed causal relationship to the substance is correct or mistaken.\n - This data group is intended to provide a single place within the health record to document the propensity for the full range of adverse reactions, from trivial to life-threatening, irrespective of the underlying physical mechanism. This includes but is not limited to:\n\t - Immune-mediated: Types I-IV (including allergic reactions and hypersensitivities); or\n\t - Non-immune-mediated: such as pseudo-allergic reactions, side effects, intolerances, and drug toxicities in individuals with impaired excretion.\n - In Release 1, all adverse reactions are assumed active in the context of a summary for exchange.\n - In future updates, it is anticipated this data group will be extended to incorporate additional detail.",
        "alias": [
          "Adverse reaction",
          "Allergy",
          "Intolerance",
          "Hypersensitivity"
        ],
        "min": 0,
        "max": "*",
        "mustSupport": true
      },
      {
        "id": "AdverseReactionRiskSummary.Data",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data",
        "short": "Data",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "BackboneElement"
          }
        ],
        "mustSupport": true
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Substancename",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "In this context, appropriate values for ‘Substance name’ include, but are not limited to:\n - A therapeutic substance administered correctly at an appropriate dosage for the individual,\n - Food,\n - Material derived from plants or animals,\n - Venom from insect stings, and\n - Physical objects commonly recorded as the proxy for a substance, such as Band-Aids or surgical tape.\n\nIt is strongly recommended that ‘Substance name’ be coded with a terminology capable of triggering decision support, where possible. Free text entry should only be permitted if no appropriate terminology is available."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-terminology",
            "valueString": "The [Adverse Reaction Agent value set](https://healthterminologies.gov.au/fhir/ValueSet/adverse-reaction-agent-1) published by the NCTS currently includes all Substances (and classes) within SNOMED CT-AU and all AMT Product (notable) concepts."
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-example",
            "valueString": "AMT provides concepts at various granularities from brand to specific substance:\n - TP: 3738011000036101|Amoxil|\n - TPUU: 4542011000036104|Amoxil Forte Sugar Free oral liquid|\n - MP: 27658006| Product containing amoxicillin|\n - MP: 831021000168104 |measles + mumps + rubella live vaccine|\n\nNote: The above examples reflect the future state of AMT, v4.\n\nSpecific substances and non-medicinal substances from SCT-AU:\n - 372687004| Amoxicillin|\n - 764147003 |Cephalosporin|\n - 111088007 | Latex |\n - 256259004 | Pollen |\n - 762952008| Peanut |\n - 1222501000168103 | Vegemite |\n - 348608005 | Surgical adhesive tape |\n - ‘Band-Aid’"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Substancename",
        "short": "Substance name",
        "definition": "Identification of a specific substance, compounded product, combination therapy product, or class of substances that is considered to have a causal link to the adverse reaction.",
        "comment": "**Considerations**\n\nIn this context, appropriate values for ‘Substance name’ include, but are not limited to:\n - A therapeutic substance administered correctly at an appropriate dosage for the individual,\n - Food,\n - Material derived from plants or animals,\n - Venom from insect stings, and\n - Physical objects commonly recorded as the proxy for a substance, such as Band-Aids or surgical tape.\n\nIt is strongly recommended that ‘Substance name’ be coded with a terminology capable of triggering decision support, where possible. Free text entry should only be permitted if no appropriate terminology is available.\n\n**Example**\n\nAMT provides concepts at various granularities from brand to specific substance:\n - TP: 3738011000036101|Amoxil|\n - TPUU: 4542011000036104|Amoxil Forte Sugar Free oral liquid|\n - MP: 27658006| Product containing amoxicillin|\n - MP: 831021000168104 |measles + mumps + rubella live vaccine|\n\nNote: The above examples reflect the future state of AMT, v4.\n\nSpecific substances and non-medicinal substances from SCT-AU:\n - 372687004| Amoxicillin|\n - 764147003 |Cephalosporin|\n - 111088007 | Latex |\n - 256259004 | Pollen |\n - 762952008| Peanut |\n - 1222501000168103 | Vegemite |\n - 348608005 | Surgical adhesive tape |\n - ‘Band-Aid’",
        "alias": [
          "agent",
          "class",
          "product",
          "drug",
          "allergen",
          "medicine"
        ],
        "min": 1,
        "max": "1",
        "type": [
          {
            "code": "CodeableConcept"
          }
        ],
        "mustSupport": true
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Activeinactivestatus",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Activeinactivestatus",
        "short": "Active/inactive status",
        "definition": "Status about whether the adverse reaction risk statement is active or inactive.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "Coding"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Verificationstatus",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Verificationstatus",
        "short": "Verification status",
        "definition": "Assertion about the certainty of the propensity, or potential future risk, of the identified 'Substance' to cause a reaction.",
        "comment": "**Considerations**\n\nDecision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "Coding"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Criticality",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "This can be regarded as a predictive judgement of a 'worst case scenario'. In most contexts 'Low' would be regarded as the default value."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Criticality",
        "short": "Criticality",
        "definition": "An indication of the potential for critical system organ damage or life threatening consequence.",
        "comment": "**Considerations**\n\nThis can be regarded as a predictive judgement of a 'worst case scenario'. In most contexts 'Low' would be regarded as the default value.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "Coding"
          },
          {
            "code": "string"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Category",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "This data element has been included because it is currently being captured in some clinical systems. This data can be derived from the Substance where coding systems are used, and is effectively redundant in that situation."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Category",
        "short": "Category",
        "definition": "Category of the identified 'Substance'.",
        "comment": "**Considerations**\n\nThis data element has been included because it is currently being captured in some clinical systems. This data can be derived from the Substance where coding systems are used, and is effectively redundant in that situation.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "Coding"
          },
          {
            "code": "string"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Onsetoflastreaction",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Onsetoflastreaction",
        "short": "Onset of last reaction",
        "definition": "The date and/or time of the onset of the last known occurrence of a reaction event.",
        "comment": "**Considerations**\n\nFor example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "dateTime"
          },
          {
            "code": "string"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Onsetoffirstreaction",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Onsetoffirstreaction",
        "short": "Onset of first reaction",
        "definition": "The onset of the first known occurrence of a reaction event.",
        "comment": "**Considerations**\n\nFor example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "dateTime"
          },
          {
            "code": "string"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Reactionmechanism",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "Immune-mediated responses have been traditionally regarded as an indicator for escalation of significant future risk. Contemporary knowledge suggests that some reactions previously thought to be immune are actually non-immune and still carry life threatening risk. \r\n\r\nImmunological testing may provide supporting evidence for the mechanism and causative substance , but no tests are 100% sensitive or specific for a sensitivity. \r\n\r\nIt is acknowledged that most clinicians will NOT be able to distinguish the mechanism of any specific reaction. However this data element is included because many legacy systems have captured this attribute."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Reactionmechanism",
        "short": "Reaction mechanism",
        "definition": "Identification of the underlying physiological mechanism for the adverse reaction.",
        "comment": "**Considerations**\n\nImmune-mediated responses have been traditionally regarded as an indicator for escalation of significant future risk. Contemporary knowledge suggests that some reactions previously thought to be immune are actually non-immune and still carry life threatening risk. \r\n\r\nImmunological testing may provide supporting evidence for the mechanism and causative substance , but no tests are 100% sensitive or specific for a sensitivity. \r\n\r\nIt is acknowledged that most clinicians will NOT be able to distinguish the mechanism of any specific reaction. However this data element is included because many legacy systems have captured this attribute.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "Coding"
          },
          {
            "code": "string"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Clinicalevidence",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "For example: an adverse reaction event; or an immunogenetic test result."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Clinicalevidence",
        "short": "Clinical evidence",
        "definition": "Summary details about evidence supporting the risk assessment for the identified 'Substance'.",
        "comment": "**Considerations**\n\nFor example: an adverse reaction event; or an immunogenetic test result.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "BackboneElement"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Clinicalevidence.Adversereactioneventsummary",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "Use to record information about a specific adverse reaction event caused by exposure to a specific substance. The substance may be recorded in the 'Specific substance' element in this archetype, or in an appropriate element in the parent archetype in which this archetype is nested.  \n  \nThis archetype is designed to be nested within the 'Adverse reaction risk summary' data group, to record details about a specific reaction event, but it could also be nested within other archetypes where clinically appropriate.  \n  \nThe scope of this archetype has deliberately focused on identifying a pragmatic data set that are used in most clinical systems or will be suitable for most common clinical scenarios; however, it permits extension of the model when additional detail is required, using the 'Reaction details', 'Exposure details', and 'Reporting details' slots. An extension may be required if a specialist allergist or immunologist needed to record a more detailed assessment as part of a report to regulatory bodies or within the context of a clinical trial."
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Clinicalevidence.Adversereactioneventsummary",
        "short": "Adverse reaction event summary",
        "definition": "Information about a specific adverse reaction event caused by exposure to a specific substance.",
        "comment": "**Considerations**\n\nUse to record information about a specific adverse reaction event caused by exposure to a specific substance. The substance may be recorded in the 'Specific substance' element in this archetype, or in an appropriate element in the parent archetype in which this archetype is nested.  \n  \nThis archetype is designed to be nested within the 'Adverse reaction risk summary' data group, to record details about a specific reaction event, but it could also be nested within other archetypes where clinically appropriate.  \n  \nThe scope of this archetype has deliberately focused on identifying a pragmatic data set that are used in most clinical systems or will be suitable for most common clinical scenarios; however, it permits extension of the model when additional detail is required, using the 'Reaction details', 'Exposure details', and 'Reporting details' slots. An extension may be required if a specialist allergist or immunologist needed to record a more detailed assessment as part of a report to regulatory bodies or within the context of a clinical trial.",
        "min": 0,
        "max": "*",
        "type": [
          {
            "code": "BackboneElement"
          }
        ],
        "mustSupport": false
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Clinicalevidence.Adversereactioneventsummary.Manifestation",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "It is strongly recommended that ‘Manifestation’ be coded with a terminology capable of triggering decision support, where possible. Free text entry should only be permitted if no appropriate terminology is available.\n\nThis data element has multiple occurrences to allow the recording of more than one manifestation per substance."
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-terminology",
            "valueString": "The [Clinical Finding value set](https://healthterminologies.gov.au/fhir/ValueSet/clinical-finding-1) published by the NCTS currently includes all Clinical findings within SNOMED CT-AU that could manifest as the result of an adverse reaction.\n\nAdditionally, the [Clinical manifestation reference set](https://healthterminologies.gov.au/fhir/ValueSet/sctau-reference-set-142341000036103) is a subset of Clinical Findings that is published as part of SNOMED CT-AU that was developed collaboratively with a number of different health jurisdictions to identify the most commonly encountered reactions."
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-example",
            "valueString": "SNOMED CT-AU:\n - 247472004 | Hives |\n - 267038008 | Oedema |\n - 62315008 | Diarrhoea |\n - 422587007 | Nausea |\n - 39579001 | Anaphylaxis |"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Clinicalevidence.Adversereactioneventsummary.Manifestation",
        "short": "Manifestation",
        "definition": "Symptom or sign observed or associated with the reaction.",
        "comment": "**Considerations**\n\nIt is strongly recommended that ‘Manifestation’ be coded with a terminology capable of triggering decision support, where possible. Free text entry should only be permitted if no appropriate terminology is available.\n\nThis data element has multiple occurrences to allow the recording of more than one manifestation per substance.\n\n**Example**\n\nSNOMED CT-AU:\n - 247472004 | Hives |\n - 267038008 | Oedema |\n - 62315008 | Diarrhoea |\n - 422587007 | Nausea |\n - 39579001 | Anaphylaxis |",
        "alias": [
          "reaction",
          "nature of reaction",
          "clinical manifestation",
          "sign",
          "symptom"
        ],
        "min": 0,
        "max": "*",
        "type": [
          {
            "code": "CodeableConcept"
          }
        ],
        "mustSupport": true
      },
      {
        "id": "AdverseReactionRiskSummary.Data.Comment",
        "extension": [
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "For example: including reason for flagging a 'Criticality' of 'High risk'; and instructions related to future exposure or administration of the Substance, such as administration within an Intensive Care Unit or under corticosteroid cover."
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Data.Comment",
        "short": "Comment",
        "definition": "Additional narrative about the propensity for the adverse reaction, not captured in other fields.",
        "comment": "**Considerations**\n\nFor example: including reason for flagging a 'Criticality' of 'High risk'; and instructions related to future exposure or administration of the Substance, such as administration within an Intensive Care Unit or under corticosteroid cover.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "string"
          }
        ],
        "mustSupport": true
      },
      {
        "id": "AdverseReactionRiskSummary.Protocol",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          }
        ],
        "path": "AdverseReactionRiskSummary.Protocol",
        "short": "Protocol",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "BackboneElement"
          }
        ],
        "mustSupport": true
      },
      {
        "id": "AdverseReactionRiskSummary.Protocol.Lastupdated",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-display-hint",
            "valueString": "orientation:right"
          },
          {
            "url": "https://aehrc.csiro.au/fhir/StructureDefinition/note-considerations",
            "valueString": "Partial dates are not permitted for contemporaneous recording.\nDate examples:\n-   March 15, 2024\n-   2015-02-07T13:28:17-05:00"
          }
        ],
        "path": "AdverseReactionRiskSummary.Protocol.Lastupdated",
        "short": "Last updated",
        "definition": "The date when the Adverse reaction risk summary data group was last updated.",
        "comment": "**Considerations**\n\nPartial dates are not permitted for contemporaneous recording.\nDate examples:\n-   March 15, 2024\n-   2015-02-07T13:28:17-05:00",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "dateTime"
          }
        ],
        "mustSupport": true
      }
    ]
  }
}